Tag: kadmon

September 28, 2017

Kadmon Closes $80.4 Million Public Offering

Kadmon Holdings announced the closing of a public offering for gross proceeds of approximately $80.4 million.
November 9, 2016

Kadmon Provides Business Update and Reports Third Quarter 2016 Financial Results

Kadmon Holdings today provided a business update, including a review of near-term clinical milestones, and reported financial and operational results...
September 22, 2016

Kadmon Initiates Placebo-Controlled Phase 2 Clinical Trial

Kadmon today announced that the first patient has been dosed in a double-blind, placebo-controlled Phase 2 clinical trial of KD025,...